SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-068719
Filing Date
2010-03-26
Accepted
2010-03-26 17:00:45
Documents
7
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1666714
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 5302
3 CERTIFICATION OF JOSEPH K. BELANOFF, M.D. PURSUANT TO RULE 13A-14(A) dex311.htm EX-31.1 9294
4 CERTIFICATION OF CAROLINE M. LOEWY PURSUANT TO RULE 13A-14(A) dex312.htm EX-31.2 9159
5 CERTIFICATION OF JOSEPH K. BELANOFF, M.D. PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 3732
6 CERTIFICATION OF CAROLINE M. LOEWY PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 3703
7 GRAPHIC g39832g86g03.jpg GRAPHIC 40792
  Complete submission text file 0001193125-10-068719.txt   1755650
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50679 | Film No.: 10708328
SIC: 2834 Pharmaceutical Preparations